DUBLIN–(BUSINESS WIRE)–The “3D Bioprinting: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claim Analysis)” report has been added to ResearchAndMarkets.com’s offering. This report captures some of the key R&D-related trends and provides competitive intelligence on … [Read more…]

BALLERUP, Denmark & DUBLIN–(BUSINESS WIRE)–#partnership—LEO Pharma, a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, and which will support the company’s overall ambition of building one of the most effective and efficient … [Read more…]

John H. Owoc will no longer serve in his current role John C. DiDonato announced as Interim CEO PEMBROKE PINES, Fla.–(BUSINESS WIRE)–Vital Pharmaceuticals, Inc. (“VPX Sports” or “Vital” or “Bang Energy” or the “Company”) announced that Founder, Chief Executive Officer (CEO) & Chief Science Officer (CSO), and Chairman John H. Owoc (“Jack”) will no longer … [Read more…]

BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first subject has been dosed in clinical trial of the Company’s B-cell lymphoma-2 (BCL2) inhibitor ICP-248 in China. ICP-248 is a novel, orally bioavailable BCL2 selective inhibitor, which aims to treat … [Read more…]

– U.S. FDA’s Oncologic Drugs Advisory Committee voted 11 to 2 in favor of the clinical benefit of the Phase III POLARIX study of Polivy in combination with R-CHP for people with previously untreated diffuse large B-cell lymphoma – This is the first treatment in 20 years to show a significant and clinically meaningful improvement … [Read more…]

– Clinical data submitted are consistent with global data and support enfortumab vedotin as a platinum-free option in patients with locally advanced or metastatic urothelial cancer who received prior treatment with a PD-1/L1 inhibitor and platinum-based chemotherapy – TOKYO & BOTHELL, Wash.–(BUSINESS WIRE)–Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Seagen … [Read more…]

NAMUR, Belgium–(BUSINESS WIRE)–Sunrise, the company revolutionising home sleep testing, announces a €17 million in funding. The successful fundraising is led by Kurma Partners and includes the exceptional entry of the European Innovation Council (EIC Fund). The Walloon start-up has also taken an important step by obtaining approval from the European (MDR) and American (FDA) medical … [Read more…]

Anita Haas, Inspirational Teacher and Advocate for Neurodiverse Students, Wins MINNDEPENDENT’s 2023 Honor Teacher Award. GOLDEN VALLEY, Minn.–(BUSINESS WIRE)–Franklin Center teacher Anita Haas has been named the recipient of MINNDEPENDENT’s 2023 Honor Teacher Award. This prestigious award recognizes exceptional teachers who have a passion for students and education. Winners of the Honor Teacher Award are … [Read more…]

BROOMFIELD, Colo.–(BUSINESS WIRE)–TransLogic™, a Swisslog Healthcare company and a leading supplier in transport automation, will participate at the 2023 PDC Summit from March 12-15 in Phoenix, Arizona. TransLogic™ invites attendees from all disciplines of healthcare to learn about the showcased services and solutions as well as experience a laser focused market message. In their new … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced its full year 2022 financial results for the period ended December 31, 2022. “We are encouraged by the results of the NAPOLI 3 trial as reported by Ipsen in November 2022 and the guidance that Ipsen has subsequently provided regarding its intention … [Read more…]